Type Mutant Stock; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Hemizygote x Noncarrier (Female x Male) 16-DEC-11 Species laboratory mouse Generation F?+F2 (08-JAN-13)
Generation DefinitionsDonating Investigator Bryan L Roth, University of North Carolina-Chapel Hill Description
Hemizygous TRE-hM3Dq transgenic mice are viable and fertile, with no reported phenotypic abnormalities. The TRE-hM3Dq transgene has a modified Tet response element (TRE or tetO) upstream of the mutant G protein-coupled receptor, hM3Dq (a human muscarinic 3 receptor with two amino acid substitutions (Y149C3.33/A239G5.46) that abolish receptor affinity for the native ligand, acetylcholine (ACh), but allow receptor binding and subsequent activation by the small pharmacologically inert molecule clozapine-N-oxide (CNO)). When bred with another mouse expressing tetracycline-controlled transactivator protein (tTA) or reverse tetracycline-controlled transactivator protein (rtTA), hM3Dq expression in the resulting double mutant offspring can be regulated with tetracycline or its analog doxycycline (dox). As designed, TRE-hM3Dq transgenic mice have no reported levels of hM3Dq activity in tTA(+dox) or rtTA(-dox) cell types. In TRE-hM3Dq transgenic tTA(-dox) or TRE-hM3Dq transgenic rtTA(+dox) cells types, hM3Dq expression results in activation of the canonical Gq pathway only following administration of CNO.These TRE-hM3Dq transgenic mice may be useful to study receptor-specific functions or general downstream cellular signaling emanating from the activated G protein-coupled receptor (GPCR). For example, when bred to a strain expressing tTA in forebrain neurons (Camk2a-tTA; see Stock No. 003010), these transgenic mice are a model allowing in vivo chemical control of neuronal activity, neuronal firing, and non-neuronal signaling.
In addition, breeding TRE-hM3Dq mice with cfos-htTA mice (Stock No. 018306) generates double transgenic offspring with hM3Dq expression in excitatory neurons that are sufficiently active to drive the c-fos promoter. Those hM3Dqfos double transgenic mice allow CNO ligand-induced, artificial reactivation of neurons associated with a specific memory. Temporal modulation may also be employed using dox. Such hM3Dqfos double transgenic mice allow one to generate and artificially-activate a synthetic memory trace, and may be useful in studying the spatial pattern of activity at the time of learning and retrieval.
Of note, the same donating investigator has sent several pharmacogenetic tool strains to The Jackson Laboratory Repository; including these Tet-responsive TRE-hM3Dq transgenic mice (Stock No. 014093) and the adora2A-rM3Ds transgenic mice (Stock No. Stock No. 017863).
Development
The TRE-HA-hM3Dq transgene was designed with a modified Tet response element (TRE or (tetO); described in detail below), a hemagglutinin epitope tag (HA), the hM3Dq sequence, and an SV40 polyA signal. The hM3Dq sequence is a Gq-coupled human M3 muscarinic DREADD (designer receptor exclusively activated by designer drug). To create the hM3Dq sequence, the wildtype human muscarinic 3 receptor (CHRM3) sequence was modified via site-directed mutagenesis to harbor two amino acid substitutions (Y149C3.33/A239G5.46) that abolish receptor affinity for the native ligand, acetylcholine (ACh), but allow receptor binding and subsequent activation by the small drug-like molecule clozapine-N-oxide (CNO).
This 2.36 kb TRE-HA-hM3Dq transgene was injected into the pronuclei of B6SJL hybrid mouse oocytes. Founder TRE-hM3Dq mice (line 1) were bred with B6;CBA-Tg(Camk2a-tTA)1Mmay/J (see Stock No. 003010) to establish the colony. TRE-hM3Dq transgenic mice were bred together or to wildtype (noncarrier) mice from the colony for approximately eight generations, and then crossed with C57BL/6J mice for one or two generations. The Camk2a-tTA transgene was removed during these breedings. Upon arrival at The Jackson Laboratory Repository, TRE-hM3Dq transgenic mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.Additional information on hM3Dq:
More information on hM3Dq or other DREADDs may be available at the University of North Carolina Designer Receptors Exclusively Activated by Designer Drugs DREADD wiki webpage.Additional information on TRE promoter:
The TRE promoter used in these transgenic mice is the Tet-responsive Ptight promoter. This Ptight promoter contains a modified Tet response element (TREmod), which consists of seven direct repeats of a 36-bp sequence each containing the 19-bp tet operator sequence (tetO). The TREmod is just upstream of a minimal human cytomegalovirus (CMV) promoter (PminCMVΔ), which lacks the enhancer that is part of the complete CMV promoter. Consequently, Ptight is silent in the absence of binding of TetR or rTetR to the tetO sequences.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 100011 B6CBAF1/J | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of CMV
017456 B6(C)-Tg(CAG-mCherry,-GAL4)769Gsn/J 017457 B6(C)-Tg(CAG-mCherry,-GAL4)774Gsn/J 021469 B6(D2)-Tg(CAG-GFP,-Uprt)985Cdoe/J 018439 B6.129S6-Tg(CAG-Bgeo,-SMN2)E9Dscd/J 006054 B6.C-Tg(CMV-cre)1Cgn/J 016197 B6.Cg-Tg(CAG-OTC/CAT)4033Prab/J 018021 B6.Cg-Tg(CAG-Tfb1m)AGsha/J 016882 B6.Cg-Tg(CMV-CASP3)14Edge/J 016908 B6.Cg-Tg(CMV-CASP3)17Edge/J 008300 B6.Cg-Tg(CMV-Klc1)73Gsn/J 008301 B6.Cg-Tg(CMV-Klc1)90Gsn/J 007237 B6.Cg-Tg(CMV-Serpine1)1Dgi/J 018056 B6.FVB-Tg(CAG-boNT/B,-EGFP)U75-56Fwp/J 017524 B6;129-Tg(CMV-Bgeo,-WGA,-ALPP)1Mgmj/J 014605 B6;129S-Tg(CMV-BBS1)6Vcs/J 017954 B6;C-Tg(CAG-Epha4/Efna5,-mCherry)1Slp/J 016532 B6N.FVB(Cg)-Tg(CAG-rtTA3)4288Slowe/J 003465 BALB/c-Tg(CMV-cre)1Cgn/J 010545 C.FVB-Tg(CAG-luc,-GFP)L2G85Chco/FathJ 014564 C57BL/6-Tg(CMV-Tsc2*)1Arbi/KlanJ 006362 C57BL/6J-Tg(CMV-Cox8a/EYFP)17J/J 010548 D1.FVB(Cg)-Tg(CAG-luc,-GFP)L2G85Chco/FathJ 018543 FVB-Tg(CAG-cat,-Twist1)1Dbsp/J 008450 FVB-Tg(CAG-luc,-GFP)L2G85Chco/J 006439 FVB-Tg(tetO/CMV-KRAS*G12C)9.1Msmi/J 018393 FVB/N-Tg(CAG-EGFP,TGFB1*)C8Akul/J 004375 FVB/N-Tg(tetO-Kras2)12Hev/J 004644 NOD.Cg Prkdcscid-Tg(CSF2)2Ygy Tg(IL3)1Ygy Tg(KITLG)3Ygy/YgyJ 013062 NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ 011066 NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CSF2)2Ygy Tg(IL3)1Ygy Tg(KITLG)3Ygy/YgyJGckRolyJ 010542 NOD.FVB-Tg(CAG-luc,-GFP)L2G85Chco/FathJ 014092 STOCK Tg(ACTB-tTA2,-MAPT/lacZ)1Luo/J 013753 STOCK Tg(CAG-KikGR)33Hadj/J 013754 STOCK Tg(CAG-KikGR)75Hadj/J 019082 STOCK Tg(CMV-GFP,-BBS4)4T25Vcs/J 002471 STOCK Tg(hCMV-cre)140Sau/J View Strains carrying other alleles of CMV (36 strains)
Strains carrying other alleles of tetO
008079 129S-Ppargtm2Yba/J 016176 B6(Cg)-Tg(tetO-Per2)2Jt/J 009602 B6.129S4(Cg)-Kcnn2tm2Jpad/J 009603 B6.129S4-Kcnn3tm1Jpad/J 017983 B6.Cg-Col1a1tm9(tetO-Dnmt3b*)Jae Gt(ROSA)26Sortm1(rtTA*M2)Jae/J 014588 B6.Cg-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1A1tm6(tetO-MSI2)Jae/J 014648 B6.Cg-Gt(ROSA)26Sortm37(H1/tetO-RNAi:Taz)Arte/ZkhuJ 006361 B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J 016998 B6.Cg-Tg(TetO-Axin1,EGFP)TA6Cos/J 003762 B6.Cg-Tg(tetFosb)4468Nes/J 007051 B6.Cg-Tg(tetO-APPSwInd)102Dbo/Mmjax 007052 B6.Cg-Tg(tetO-APPSwInd)107Dbo/Mmjax 007049 B6.Cg-Tg(tetO-APPSwInd)885Dbo/Mmjax 007618 B6.Cg-Tg(tetO-Arntl)1Jt/J 017555 B6.Cg-Tg(tetO-CALY)5Cber/J 008277 B6.Cg-Tg(tetO-Clockm1Jt)CL57Jt/J 008468 B6.Cg-Tg(tetO-DTA)1Gfi/J 017791 B6.Cg-Tg(tetO-Hamp)2181Nca/J 009344 B6.Cg-Tg(tetO-Ifng)184Pop/J 009136 B6.Cg-Tg(tetO-Kcnj2,lacZ)1Gogo/J 013583 B6.Cg-Tg(tetO-LRRK2)C7874Cai/J 020652 B6.Cg-Tg(tetO-Mif)279Aren/J 017331 B6.Cg-Tg(tetO-Ppp3ca*)11255Kndl/J 017332 B6.Cg-Tg(tetO-Ppp3ca*)13967Kndl/J 017330 B6.Cg-Tg(tetO-TAg*)175Kndl/J 006234 B6.Cg-Tg(tetO-cre)1Jaw/J 005738 B6.FVB-Tg(tetO-EGFP,-Tgfbr2)8Mcle/J 006911 B6;129-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm2(tetO-Pou5f1)Jae/J 011001 B6;129S4-Col1a1tm1(tetO-Pou5f1,-Klf4,-Sox2,-Myc)Hoch/J 016836 B6;129S4-Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm7(tetO-HIST1H2BJ/GFP)Jae/J 012433 B6;C3-Tg(ACTA1-rtTA,tetO-cre)102Monk/J 002709 B6;C3-Tg(TettTALuc)1Dgs/J 016841 B6;C3-Tg(tetO-TARDBP)12Vle/J 014650 B6;C3-Tg(tetO-TARDBP*)4Vle/J 012450 B6;D2-Tg(tetO-SNCA)1Cai/J 008344 B6;DBA-Tg(Fos-tTA,Fos-EGFP*)1Mmay Tg(tetO-lacZ,tTA*)1Mmay/J 008082 B6;SJL-Tg(Tagln-tTA)1Mrab Tg(tetO-Mcpt1)1Mrab/J 010575 B6;SJL-Tg(tetO-Egfr*)2-9Jek/J 010577 B6;SJL-Tg(tetO-Erbb2*)8-4Jek/J 002621 B6;SJL-Tg(tetop-lacZ)2Mam/J 006004 B6C3-Tg(tetO-APPSwInd)885Dbo/Mmjax 016976 B6C3-Tg(tetO-SNCA*A53T)33Vle/J 018913 B6N.Cg-Tg(tetO-GFP,-lacZ)G3Rsp/J 006244 C.Cg-Tg(tetO-cre)1Jaw/J 017719 C3HeB/FeJ-Tg(tetO-TAg)1Efr/J 017955 C57BL/6-Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/J 005706 C57BL/6-Tg(tetO-CDK5R1/GFP)337Lht/J 006618 C57BL/6-Tg(tetO-COX8A/EYFP)1Ksn/J 017613 C57BL/6-Tg(tetO-Cdkn1b)1Scpr/J 013729 C57BL/6-Tg(tetO-EDN1,-lacZ)9Mhus/J 010713 C57BL/6-Tg(tetO-GFP/tetX)5696Stl/J 013728 C57BL/6-Tg(tetO-NOS2,-lacZ)240iMhus/J 016181 C57BL/6-Tg(tetO-Nr1d1)1Schb/J 008278 C57BL/6J-Tg(tetO-Clock)1Jt/J 021065 FVB(C)-Tg(tetO-Npc1/YFP)1Mps/J 017542 FVB-Tg(Myh6/tetO-ATP2B4)1Jmol/J 016571 FVB-Tg(Myh6/tetO-Gata6)2Jmol/J 014155 FVB-Tg(Myh6/tetO-Itpr1)22.3Jmol/J 014153 FVB-Tg(Myh6/tetO-Itpr2)3.11Jmol/J 014154 FVB-Tg(Myh6/tetO-Itpr2)4.9Jmol/J 012684 FVB-Tg(Myh6/tetO-POSTN)22.1Jmol/J 010580 FVB-Tg(Myh6/tetO-PRKCA*)1Jmk/J 013156 FVB-Tg(tetO-CDK5R1*)1Vln/J 013777 FVB-Tg(tetO-Cacna1g)1Jmol/J 013778 FVB-Tg(tetO-Cacnb2)1Jmol/J 013779 FVB-Tg(tetO-Cacnb2)2Jmol/J 013780 FVB-Tg(tetO-Cib1)1Jmol/J 010578 FVB-Tg(tetO-Dusp6)1Jmol/J 017333 FVB-Tg(tetO-Gnai2*,-lacZ)382Kndl/J 008685 FVB-Tg(tetO-Kdr*)4377.5Rwng/J 015815 FVB-Tg(tetO-MAPT*P301L)#Kha/JlwsJ 008695 FVB-Tg(tetO-MET)23Rwng/J 012387 FVB-Tg(tetO-Ppargc1a)1Dpk/J 012385 FVB-Tg(tetO-Ppargc1b)7Dpk/J 006439 FVB-Tg(tetO/CMV-KRAS*G12C)9.1Msmi/J 008244 FVB.Cg-Tg(tetO-cre)1Jaw/J 012459 FVB/N-Tg(Myh6*/tetO-Capn1)L2Gwd/J 005941 FVB/N-Tg(tetO-Aurkb,lacZ)41Kra/J 006202 FVB/N-Tg(tetO-BCR/ABL1)2Dgt/J 014547 FVB/N-Tg(tetO-Fasl)BDepa/J 019376 FVB/N-Tg(tetO-MYC)36aBop/J 003315 FVB/N-Tg(tetORo1-lacZ)3Conk/J 005076 NOD.Cg-Tg(tetO-EGFP/FADD)1Doi/DoiJ 006999 STOCK Dbttm1Geh Tg(Cebpb-tTA)5Bjd Tg(tetO-DBT)A1Geh/J 011004 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm3(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J 011011 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm4(tetO-Pou5f1,-Sox2,-Klf4,-Myc)Jae/J 011013 STOCK Gt(ROSA)26Sortm1(rtTA*M2)Jae Col1a1tm5(tetO-Pou5f1,-Klf4,-Myc)Jae/J 018999 STOCK Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/J 017596 STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#aAhmb/J 017597 STOCK Gt(ROSA)26Sortm1.1(rtTA,EGFP)Nagy Smn1tm1Msd Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb Tg(tetO-SMN2,-luc)#bAhmb/J 015838 STOCK Tg(Camk2a-tTA)1Mmay Tg(tetO-ABL1*P242E*P249E)CPdav/J 008755 STOCK Tg(Ins2-rtTA)2Efr Tg(teto-DTA)1Gfi/J 012477 STOCK Tg(Myh6*/tetO-GCaMP2)1Mik/J 016572 STOCK Tg(Myh6/tetO-Gata4)1Jmol/J 014544 STOCK Tg(tetO-ABL1*P242E*P249E)CPdav/J 008790 STOCK Tg(tetO-DISC1*)1001Plet/J 008168 STOCK Tg(tetO-DTA)1Gfi/J 017755 STOCK Tg(tetO-GCAMP2)12iRyu/J 005104 STOCK Tg(tetO-HIST1H2BJ/GFP)47Efu/J 005699 STOCK Tg(tetO-Ipf1,EGFP)956.6Macd/J 005728 STOCK Tg(tetO-Ipf1,lacZ)958.1Macd/J 012441 STOCK Tg(tetO-LRRK2*G2019S)E3Cai/J 017599 STOCK Tg(tetO-SMN2,-luc)#aAhmb/J 017600 STOCK Tg(tetO-SMN2,-luc)#bAhmb/J 012442 STOCK Tg(tetO-SNCA*A53T)E2Cai/J 006224 STOCK Tg(tetO-cre)1Jaw/J 017906 STOCK Tg(tetO-hop/EGFP,-COP4/mCherry)6Kftnk/J 012345 STOCK Tg(tetO-tdTomato,-Syp/EGFP*)1.1Luo/J 012449 STOCK Tg(teto-LRRK2)C7874Cai/J View Strains carrying other alleles of tetO (109 strains)
Tet Expression Systems
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
- Potential model based on transgenic expression of an ortholog of a human gene that is associated with this disease. Phenotypic similarity to the human disease has not been tested. Abdominal Muscles, Absence of, with Urinary Tract Abnormality and Cryptorchidism (CHRM3)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cancer Research
Growth Factors/Receptors/Cytokines
Cell Biology Research
Signal Transduction
Diabetes and Obesity Research
Insulin Receptors and Growth Factors
Immunology, Inflammation and Autoimmunity Research
Growth Factors/Receptors/Cytokines
Intracellular Signaling Molecules
Neurobiology Research
Optogenetic and Pharmacogenetic tools
Pharmacogenetic tools
Receptor Defects
G protein-coupled receptor
Tet Expression System
tTA/rtTA Responsive Strains
Research Tools
Cancer Research
Tetop Tet System
Cardiovascular Research
Tetop Tet System
Genetics Research
Mutagenesis and Transgenesis: Tetop Tet System
Neurobiology Research
Tetop Tet System
Reproductive Biology Research
Tetop Tet System
Tet Expression Systems
tTA/rtTA Responsive Strains
| Allele Symbol | Tg(tetO-CHRM3*)1Blr | ||
|---|---|---|---|
| Allele Name | transgene insertion 1, Bryan Roth | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | TRE-HA-hM3Dq; TRE-hM3Dq; tetO-hM3Dq; | ||
| Mutation Made By | Bryan Roth, University of North Carolina-Chapel Hill | ||
| Strain of Origin | (B6 x SJL)F1 | ||
| Expressed Gene | CHRM3, cholinergic receptor, muscarinic 3, human | ||
| Promoter | tetO, tet operator, | ||
| Promoter | CMV, cytomegalovirus, human | ||
| Molecular Note | The Tet-responsive P promoter which consists of seven direct repeats of 36-bp sequence each containing the 19-bp tet operator sequence (tetO) is just upstream of a minimal human cytomegalovirus (CMV) promoter. This is upstream of a hemagglutinin epitoptag and a Gq-coupled human M3 muscarinic receptor. The wildtype human muscarinic 3 receptor sequence was modified via site-directed mutagenesis to harbor two amino acid substitutions (Y149C and A239G) that abolish receptor affinity for the native ligand,acetylcholine (ACh), but allow receptor binding and subsequent activation by the small drug-like molecule clozapine-N-oxide (CNO). [MGI Ref ID J:154952] | ||
Genotyping Protocols
** human CHRM3*A239G, Pyrosequencing
** human CHRM3*Y149C, Pyrosequencing
Tg(tetO-CHRM3*)1Blr, Separated PCR
Helpful Links
Genotyping resources and troubleshooting
Alexander GM; Rogan SC; Abbas AI; Armbruster BN; Pei Y; Allen JA; Nonneman RJ; Hartmann J; Moy SS; Nicolelis MA; McNamara JO; Roth BL. 2009. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 63(1):27-39. [PubMed: 19607790] [MGI Ref ID J:154952]
Tg(tetO-CHRM3*)1Blr relatedGarner AR; Rowland DC; Hwang SY; Baumgaertel K; Roth BL; Kentros C; Mayford M. 2012. Generation of a synthetic memory trace. Science 335(6075):1513-6. [PubMed: 22442487] [MGI Ref ID J:181832]
Animal Health Reports
Room Number AX18
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, transgene carrier mice may be bred together or to wildtype (noncarrier) mice from the colony. The donating investigator reports they have not tried to generate homozygous mice (November 2011). Mating System Hemizygote x Noncarrier (Female x Male) 16-DEC-11
| Pricing for USA, Canada and Mexico shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $232.00 Female or Male Hemizygous for Tg(tetO-CHRM3*)1Blr
Price per Pair (US dollars $) Pair Genotype $296.00 Hemizygous for Tg(tetO-CHRM3*)1Blr x Noncarrier $296.00 Noncarrier x Hemizygous for Tg(tetO-CHRM3*)1Blr Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Pricing for International shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $301.60 Female or Male Hemizygous for Tg(tetO-CHRM3*)1Blr
Price per Pair (US dollars $) Pair Genotype $384.80 Hemizygous for Tg(tetO-CHRM3*)1Blr x Noncarrier $384.80 Noncarrier x Hemizygous for Tg(tetO-CHRM3*)1Blr Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
|
|
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 100011 B6CBAF1/J | (approximate) | |
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.